Exiqon Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
100
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$95.2M
Exiqon General Information
Description
Operator of a biotechnology company. The company operates through the life sciences and diagnostics segments. It provides products for microRNA research.
Contact Information
Website
www.exiqon.comCorporate Office
- Skelstedet 16
- 2950 Vedbaek
- Denmark
Corporate Office
- Skelstedet 16
- 2950 Vedbaek
- Denmark
Exiqon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 28-Jun-2016 | $95.2M | Completed | Generating Revenue | ||
| 5. PIPE | 28-Jun-2011 | Completed | Generating Revenue | |||
| 4. IPO | 29-May-2007 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 10-Jul-2005 | Completed | Generating Revenue | |||
| 2. Later Stage VC | $15.8M | $18.8M | Completed | Generating Revenue | ||
| 1. Later Stage VC | 12-Feb-2003 | $3M | $3M | Completed | Generating Revenue |
Exiqon Comparisons
Industry
Financing
Details
Exiqon Competitors (6)
One of Exiqon’s 6 competitors is KBI BioPharma, a Formerly VC-backed company based in Durham, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| KBI BioPharma | Formerly VC-backed | Durham, NC | ||||
| Xoma | Corporate Backed or Acquired | Emeryville, CA | ||||
| Fulgent Genetics | Formerly VC-backed | El Monte, CA | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Roche | Corporation | Basel, Switzerland |
Exiqon Patents
Exiqon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170017820-A1 | Automatic processing selection based on tagged genomic sequences | Inactive | 14-Jul-2015 | ||
| WO-2017009718-A1 | Automatic processing selection based on tagged genomic sequences | Inactive | 14-Jul-2015 | ||
| WO-2016134727-A1 | A microrna-based method for assessing the prognosis of a prostate cancer patient | Inactive | 27-Feb-2015 | ||
| JP-2018507692-A | Prognostic evaluation method for prostate cancer patients based on microrna | Active | 27-Feb-2015 | ||
| JP-2018504915-A | A microrna-based method for early detection of prostate cancer in urine | Pending | 11-Feb-2015 | C12Q1/6886 |
Exiqon Signals
Exiqon Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Danske Bank | Corporation | Minority | ||
| Lønmodtagernes Dyrtidsfond Fonde | Limited Partner | Minority | ||
| Noble Resources Trading Holdings | Corporation | Minority | ||
| Scandinavian Life Science Venture | Venture Capital | Minority | ||
| Teknoinvest | Venture Capital | Minority |
Exiqon Acquisitions (1)
Exiqon’s most recent deal was a Merger/Acquisition with Oncotech for . The deal was made on 01-Feb-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Oncotech | 01-Feb-2008 | Merger/Acquisition | Laboratory Services (Healthcare) |
Exiqon Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Oncotech | Tustin, CA | 1985 |
Exiqon FAQs
-
When was Exiqon founded?
Exiqon was founded in 1995.
-
Where is Exiqon headquartered?
Exiqon is headquartered in Vedbaek, Denmark.
-
What is the size of Exiqon?
Exiqon has 100 total employees.
-
What industry is Exiqon in?
Exiqon’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Exiqon a private or public company?
Exiqon is a Private company.
-
What is the current valuation of Exiqon?
The current valuation of Exiqon is .
-
What is Exiqon’s current revenue?
The current revenue for Exiqon is .
-
How much funding has Exiqon raised over time?
Exiqon has raised $102M.
-
Who are Exiqon’s investors?
Danske Bank, Lønmodtagernes Dyrtidsfond Fonde, Noble Resources Trading Holdings, Scandinavian Life Science Venture, and Teknoinvest are 5 of 7 investors who have invested in Exiqon.
-
Who are Exiqon’s competitors?
KBI BioPharma, Xoma, Fulgent Genetics, Ambry Genetics, and Roche are some of the 6 competitors of Exiqon.
-
When was Exiqon acquired?
Exiqon was acquired on 28-Jun-2016.
-
Who acquired Exiqon?
Exiqon was acquired by Qiagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process